Form 8-K - Current report:
SEC Accession No. 0001601485-25-000108
Filing Date
2025-08-07
Accepted
2025-08-07 16:33:40
Documents
20
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K angn-20250807.htm   iXBRL 8-K 23968
2 EX-99.1 a2025-08x07xxeltxxx2q25f.htm EX-99.1 17893
6 a2025-08x07xxeltxxx2q25f001.jpg GRAPHIC 209092
7 a2025-08x07xxeltxxx2q25f002.jpg GRAPHIC 151014
8 a2025-08x07xxeltxxx2q25f003.jpg GRAPHIC 87906
9 a2025-08x07xxeltxxx2q25f004.jpg GRAPHIC 172116
10 a2025-08x07xxeltxxx2q25f005.jpg GRAPHIC 249020
11 a2025-08x07xxeltxxx2q25f006.jpg GRAPHIC 263444
12 a2025-08x07xxeltxxx2q25f007.jpg GRAPHIC 156420
  Complete submission text file 0001601485-25-000108.txt   1944405

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20250807.xsd EX-101.SCH 1870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20250807_lab.xml EX-101.LAB 22786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20250807_pre.xml EX-101.PRE 13130
23 EXTRACTED XBRL INSTANCE DOCUMENT angn-20250807_htm.xml XML 2725
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 251194739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)